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Cbfa1, a Candidate Gene for Cleidocranial
Dysplasia Syndrome, Is Essential for Osteoblast
Differentiation and Bone Development
Florian Otto,1,6,7 Anders P. Thornell,1,6,8 and CBFA3; see Ito, 1996, for alternative nomencla-
tures), and a common b subunit is encoded by the CBFBTessa Crompton,1 Angela Denzel,1
Kimberly C. Gilmour,1 Ian R. Rosewell,1 gene (reviewed in Speck and Terryl, 1995). The CBFa
proteins share a conserved 128 amino acid domain,Gordon W. H. Stamp,2 Rosa S. P. Beddington,3
Stefan Mundlos,4,9 Bjorn R. Olsen,4 called the runt domain because of its homology to the
Drosophila pair-rule gene runt.Paul B. Selby,5 and Michael J. Owen1,10
1Imperial Cancer Research Fund CBF and Runt proteins bind the enhancer core se-
quence TGYGGT, a sequence motif that is present inLincoln's Inn Fields
London WC2A 3PX, United Kingdom transcriptional enhancers of many genes expressed in
cells of hematopoietic origin and in enhancers localized2Royal Postgraduate Medical School
Hammersmith Hospital within the LTR of retroviruses (reviewed in Speck and
Terryl, 1995). More recently, a CBF consensus bindingDepartment of Histopathology
London W12 0HS, United Kingdom site was shown to be an important regulatory element
for osteoblast-specific transcriptional activation (Ducy3National Institute for Medical Research
The Ridgeway, Mill Hill and Karsenty, 1995; Geoffroy et al., 1995: Banerjee et
al., 1996).London NW7 1AA, United Kingdom
4Department of Cell Biology Disruption of the mouse Cbfa2 and Cbfb genes re-
sulted in a lethal phenotype around 12.5 days postcoi-Harvard Medical School
Boston, Massachusetts 02115 tum (dpc), owing to hemorrhaging within the central
nervous system. Cbfa2- and Cbfb-deficient embryos5Life Sciences Division
Oak Ridge National Laboratory showed a total lack of fetal liver hematopoiesis (Okuda
et al., 1996; Sasaki et al., 1996; Wang et al., 1996a,1060 Commerce Park Drive
Oak Ridge, Tennessee 37830±6480 1996b), suggesting that this transcription-factor com-
plex plays a key role in hematopoietic development. To
elucidate the role of Cbfa1 in vivo, we have introduced
a germline mutation into mice that results in an inabilitySummary
to produce a Cbfa1 gene product. Mice homozygous
for this mutation show a block in osteoblast develop-We have generated Cbfa1-deficient mice. Homozy-
ment from mesenchyme and thus no ossification. Het-gous mutants die of respiratory failure shortly after
erozygous mice showspecific bone defects that recapit-birth. Analysis of their skeletons revealed an absence
ulate the phenotype of the human skeletal disorderof osteoblasts and bone. Heterozygous mice showed
named cleidocranial dysplasia (CCD). We further showspecific skeletal abnormalities that are characteristic
that the Cbfa1 gene is deleted in a radiation-inducedof the human heritable skeletal disorder, cleidocranial
mouse model of CCD.dysplasia (CCD). These defects are also observed in
a mouse Ccd mutant for this disease. The Cbfa1 gene
was shown to be deleted in the Ccd mutation. Analysis Results
of embryonic Cbfa1 expression using a lacZ reporter
gene revealed strong expression at sites of bone for- Targeting of the Cbfa1 Gene
mationprior to theearliest stagesof ossification. Thus, Cbfa1 was mutated in ES cells using replacement-type
the Cbfa1 gene is essential for osteoblast differentia- targeting vectors using the strategy shown in Figure 1a.
tion and bone formation, and the Cbfa1 heterozygous Correctly targeted G418-resistant colonies were identi-
mouse is a paradigm for a human skeletal disorder. fied by Southern blot analysis of SacI-digested ES cell
genomic DNAusing theprobe shown inFigure 1a. Of 860
G418-resistant ES cell colonies screened, 10 correctlyIntroduction
targeted colonies were identified. There was no sig-
nificant increase in targeting frequency when the con-The core-binding factor (CBF) transcription factors are
struct containing a DTA selection cassette was used.a family of heterodimeric proteins of two unrelated sub-
Five different homologously targeted ES cell clonesunits comprising a DNA binding a subunit and a non-
were injected into C57BL/6 blastocysts, and one lineDNA-binding b subunit. The mammalian CBFa subunits
was transmitted through the germ line.are encoded by three distinct genes (CBFA1, CBFA2,
To verify the structure of the targeted locus on both
sides, genomic DNA from wild type and heterozygous
mice was hybridized to probes A and C (Figure 1a). The6These authors contributed equally to this work.
7Present address: Department of Haematology/Oncology, University probes hybridized to fragments of the sizes predicted for
of Freiburg Medical Center, 79106 Freiburg, Germany. the wild-type allele and a correctly targeted replacement
8Present address: CMB, ScheelevaÈgen 12A, Astra Draco Lund, (Figures 1b and 1c). The existence of a single integration
22100 Lund, Sweden.
site at the targeted locus was verified on SacI-digested9Present address: Department of Pediatrics, Johannes-Gutenberg-
DNA with probe B (Figure 1a), giving a single 5.6 kbUniversity, 55101 Mainz, Germany.
10To whom correspondence should be addressed. fragment (data not shown).
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Figure 2. Lack of Ossification in Cbfa1 Mutant Mice
Day 17.5 postcoitum wild type (a) and homozygous mutant (b) em-
bryos were stained with Alcian blue/Alizarin red. Membranous and
endochondral ossification are absent in Cbfa12/2 mice. Bone is
stained red and cartilage blue.
about one-third (data not shown). They exhibited a char-
acteristic facies from about 16.5 dpc onward with a
foreshortened nose.
To ensure that the homozygous Cbfa1 mutant mice
did not express any detectable Cbfa1 protein, Western
Figure 1. Generation of Cbfa1 Mutant Mice by Gene Targeting blot analysis was performed on bone tissue isolated
(a) Schematic diagram of the Cbfa1 locus, the targeting vector, and from 16.5 and 18 dpc embryos using an anti-Cbfa1 anti-
the targeted allele. Restriction enzyme sites are indicated (B, BglII; serum that specifically detects Cbfa1 as a protein of
E, EcoRI; N, NotI; S, SacI; X, XhoI). The closed box corresponds to
about 60 kDa in wild-type mice. No Cbfa1 protein orthe exon containing the Q/A repeat domain of the Cbfa1 gene.
truncated product was detectable in lysates from null(b) Southern blot analysis showing correct 59 targeting of the Cbfa1
embryos (data not shown).locus. Genomic DNA samples were prepared from tails of homozy-
gous (2/2), heterozygous (1/2), and wild-type (1/1) mice and were
digested with EcoRI and probed as indicated (probe A). The resulting Cbfa1 Mutant Embryos Have a Delayed Osteogenesis
10 and 7.3 kb bands correspond to the wild-type and mutated geno- The small size of Cbfa12/2 embryos relative to heterozy-
types, respectively.
gous or wild-type littermates prompted us to analyze(c) Southern blot analysis showing correct 39 targeting of the Cbfa1
the skeletons of these mice. Skeletons were preparedlocus. Genomic DNA from wild-type (1/1) or heterozygous (1/2)
from homozygous mutant and wild-type 17.5 dpc em-mice were digested with XhoI and hybridized with probe C. The
germline and targeted alleles are indicated. bryos and were stained with Alcian blue and Alizarin red
dyes, which detect cartilage and bone tissue, respec-
tively. As shown in Figure 2a, skeletons of 17.5 dpc wild-Homozygous Cbfa1-Null Mutants Are Small
type mice showed ossification in the skull, vertebraland Die at Birth of Respiratory Failure
arches, ribs, clavicles, scapulae, pelvis, long bones,A total of 170 pups from heterozygous matings were
metacarpals, and metatarsals. In contrast, skeletonsgenotyped by Southern blot analysis between 10 days
from Cbfa1-null mice at the same embryonic age exhib-and 3 weeks of age, and none were homozygous for
ited an almost complete absence of mineralized bonethe Cbfa1 mutation. Fifty-seven (34%) were wild type,
tissue that should stain in red (Figure 2b). Cartilage for-and 113 (66%) were heterozygous for the mutant alleles.
mation, however, was grossly unaffected by the muta-To delineate when Cbfa1 homozygous mutant mice die,
tion (Figure 2b). At the time of birth, homozygous mutantyolk sac or tail DNA from 10.5±19 dpc embryos was
mice showed some small areas of mineralization (dataanalyzed. Of a total of 152 embryos, there were 38 wild
not shown). As detailedbelow, these areas didnot corre-type, 77 heterozygous, and 37 homozygous mutant
spond to any ossification.Cbfa1 embryos, suggesting that early postpartum death
occurred.
Skeletal Abnormalities in Mice HeterozygousTo elucidate the cause of death in Cbfa12/2 mice,
for the Cbfa1 Mutationpups from heterozygote intercrosses were delivered by
Analysis of the skeletons of Cbfa11/2 mice also showedCaesarean section at 18.5 or 19.5 dpc. The majority
some abnormalities. The most prominent defects werelived, but some pups sporadically gasped for air at irreg-
hypoplasia of the clavicle and delayed development ofular intervals, and after 20 min there was no sign of life.
membranous bones. In newborn Cbfa11/2 mice, theAll the pups that failed to breathe were subsequently
clavicle was barely visible when compared to wild-typeshown to be homozygous mutant mice, and none of the
littermates and merely consisted of a lateral rudimentother littermates were Cbfa12/2.
(Figures 3a and 3b). There was also delayed ossificationWhen compared to their littermates, Cbfa12/2 em-
bryos were smaller, and their weight was reduced by of the cranial bones resulting in an open anterior and
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and homozygous mutant embryos for reporter b-galac-
tosidase activity (Figure 4). No difference in the pattern
of staining could be discerned between null and hetero-
zygous embryos, although the staining intensity was
higher in homozygous embryos. In general, expression
was restricted almost entirely toprospective bone tissue
and to the notochord and its derivative, the nucleus
pulposus. Weak staining was first observed at 9.5 dpc
only in the notochord underlying the mid- and hindbrain
(data not shown). A day later, notochord expression
extended into the trunk, and expression was also evi-
dent in mesoderm corresponding to the site where the
shoulder bones (scapula and clavicle) will develop (Fig-
ure 4A, arrowhead). By 11.5 dpc the maxillary and man-
dibular components of the first branchial arch also
stained (Figure 4B, arrowhead), as did the developing
humerus in the forelimb (Figure 4B). At 12.5 dpc,
b-galactosidase activity was most prominent in the ribs
and vertebral bodies of the spinal column, the devel-
oping bones of the limbs, the shoulder and pelvic gir-
dles, the jaw, and the skull (Figures 4C and 4D). The
dorsal aspect of the genital tubercle was also stained
(Figure 4G), and nascent mammary gland epithelium
expressed b-galactosidase (Figure 4I). Transverse sec-
tions through the radius and ulna revealed that the peri-
osteal mesenchyme contained b-galactosidase activity
(Figure 4H). The nucleus pulposus was stained through-
out the length of the vertebral column (Figure 4J).
Histological Abnormalities
In order to investigate theprecise nature of the observed
skeletal defects, a detailed histological analysis was
performed. Both wild-type and heterozygous embryos
showed endochondral ossification centers at 16.5 dpc,
with vascularization and population of the marrow byFigure 3. Skeletal Phenotype in Newborn Heterozygous Cbfa1
hematopoetic cells (Figures 5a and 5b). Ossification wasMutant Mice
more advanced in the wild-type embryos, but in the(a and b) Clavicle, scapula, and forelimb skeleton of 1/1 (a) and
adult Cbfa11/2 mice, epiphyseal growth-plate structure1/2 (b) mice. Note the clavicular rudiment and the missing deltoid
tuberosity of the humerus in heterozygous animals. and differentiation were only slightly disturbed. In con-
(c and d) Neurocranium of Cbfa11/1 (c) and Cbfa11/2 (d) mice. Su- trast, theCbfa12/2 mice failed to show detectable osteo-
tures and fontanellesare widened inheterozygous mice. The parietal blastic differentiation and lacked ossification centers or
and interparietal bones are hypoplastic. Numerous small Wormian
marrow formation (Figures 5c and 5h). The periostealbones are present.
mesenchyme was thinner (Figure 5h). The cartilage was(e and f) Hyoid bone and sternum with ribs. Hypoplastic hyoid bone
underdeveloped but showed some organization intowith delayed ossification in 1/2 mice (f) as compared to a wild-type
littermate control (e). Wider xiphoid process of the sternum with two growth plates near the diaphyseal end plates at 19.5
well-separated ossification centers in heterozygous mice (f). dpc. While no osteoid was observed, there was patchy
calcification of the cartilaginous tissue matrix in the fe-
mur, tibia, and vertebrae, giving a reticulated pattern in
posterior fontanelle, as well as wide cranial sutures (Fig- the diaphyseal regions (Figure 5h).
ures 3c and 3d). The parietal and interparietal bones At 19.5 dpc, the clavicular structure of wild-type em-
were also much reduced in size, and multiple Wormian bryos was well developed, with a medial cartilaginous
bones were present (Figures 3c and 3d). Other notable head from which a growth plate extended laterally with
skeletal defects in Cbfa11/2 mice were the hypoplastic endochondral ossification. Organization and develop-
nature of the hyoid bone and a wider-than-normal ment of the lateral intramembranous bone was also
xiphoid process with two well-separated ossification apparent (Figure 5d). The clavicles of Cbfa11/2 mice
centers (Figures 3e and 3f). The pubic and ischial bones showed a slightly less active periclavicular mesenchyme
were widely separated and hypoplastic (data not with less advanced cartilaginous differentiation at 16.5
shown). dpc, but with organizing cartilage at 19.5 dpc (Figure
5g). In contrast to other skeletal development, however,
the heterozygotes showed neither surface osteoblasticExpression Pattern of Cbfa1 during Development
The expression pattern of Cbfa1 during development differentiation nor intramembranous bone formation lat-
erally. Adult Cbfa11/2 mice had a solid cartilaginous barwas assessed up to 12.5 dpc by staining heterozygous
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Figure 4. b-galactosidase Activity in Cbfa1
Heterozygous and Homozygous Embryos
(A) posterior view of 10.5 dpc 2/2 embryo
showing staining in the prospective shoulder
region (arrowhead). Bar 5 450 mm.
(B±D) 1/2 embryos. (B) Lateral view of 11.5
dpc embryo showing staining in the maxillary
(arrowhead) and mandibular processes of the
first branchial arch, and in the scapula and
developing humerus of the forelimb. Bar 5
450 mm. (C) Lateral view of 12.5 dpc embryo
showing staining in the limb bones and jaw.
Bar 5 2 mm. (D) Lateral view of a bisected
12.5 dpc embryo showing staining in the ver-
tebral bodies, the ribs and skull. Bar 5 1 mm.
(E) Dissected shoulder region from a 12.5 dpc
2/2 embryo. All developing bones are
stained. Bar 5 500 mm.
(F) Lateral view of a 12.5 dpc 1/2 embryo.
The developing clavicle is marked by an ar-
rowhead. Bar 5 320 mm.
(G±J) 2/2 embryos. (G) Dissected pelvic re-
gion from a 12.5dpc 2/2 embryo. The genital
tubercle is marked by an arrowhead. Bar 5
500 mm. (H) Transverse section through the
radius and ulna showing staining in periosteal
mesenchyme. Bar 5 100 mm. (I) Section
through a mammary gland showing staining
in the epithelium. Bar 5 100 mm. (J) Trans-
verse section through the vertebral column
showing staining in the notochord or nucleus
pulposus. Bar 5 100 mm.
within a thick fibrous sheath; the cartilage appeared similar distribution in developing epiphyses (data not
shown).disorganized and showed no matrix calcification (data
not shown). No cellular clavicular mesenchyme was Examination of blood smears of 16.5 dpc Cbfa12/2
mice revealed an increase of between 10- to 100-foldidentified in the Cbfa12/2 mice, and thus there was no
cartilaginous head identifiable. In some mice, a thin fi- in primitive nucleated erythrocytes when compared to
wild-type littermates (data not shown).brovascular band without active proliferation, as judged
by the absence of mitotic activity, was identified in the Except for the lungs, all internal organs appeared to
be normally developed for gestational age and propor-region of the clavicle (data not shown).
When compared to wild-type mice, the skulls of tionate to size in both Cbfa12/2 and Cbfa11/2 mice. The
lungs were underinflated and showed vascular conges-Cbfa11/2 mice had slightly thinner cartilage plates with
barely detectable intramembranous ossification at 16.5 tion in the live-born Cbfa12/2 mice, although bronchio-
alveolar development was normal. Their appearancedpc, but at 19.5 dpc ossification was apparent. Cbfa12/2
mice had thinner cartilaginous plates, and the cellular was consistent with an asphyxial mode of death (data
not shown).mesenchymal layer giving rise to intramembranous ossi-
fication was absent (data not shown).
The developmentof the primordium of the tooth struc- Cbfa1 Is Deleted in the Mouse Ccd Mutation
The Ccd mouse is a radiation-induced mutant (Selbyture was slightly delayed but structurally normal in het-
erozygotes. In Cbfa12/2 mice, these primordia were and Selby, 1978) with a phenotype very similar to human
CCD patients. Since thephenotype of heterozygous Ccdseverely hypoplastic, although differentiation into the
different layers was recognizable (data not shown). mice is also virtually indistinguishable from heterozy-
gous Cbfa1 mutant mice, we investigated whether theThe lack of osteoblast differentiation in Cbfa12/2 mice
revealed by this histological analysis was confirmed by Cbfa1 gene is affected in Ccd mutant mice. DNA from
mice heterozygous for the Ccd mutation on a C57BL/determining the expression of alkaline phosphatase, an
early marker of osteoblast differentiation. In the wild- 10 background and for the wild-type allele on an M.
castaneus background was analyzed by Southern blot-type mice, there was intense reactivity in the surface
osteoblasts around the developing epiphyses, and ting using a Cbfa1 cDNA probe. As shown in Figure 6a,
different size bands hybridizing with the Cbfa1 probestaining was also observed in the surrounding mesen-
chyme and on osteocytes and osteoblasts in the cancel- were observed in the C57BL/10 and M. castaneus ge-
netic backgrounds. The C57BL/10 allele was specificallylous area of the bone (Figure 5f). In contrast, Cbfa12/2
mice showed weak orabsent staining in the perichondral absent in Ccd mice, demonstrating that the Cbfa1 gene
is at least partially deleted.mesenchyme in the predicted epipyseal areas with no
surface staining (Figure 5i). The heterozygote mice A human locus for CCD has been identified on chro-
mosome 6p21 close to the TCTE1 gene (Mundlos et al.,showed less abudant staining than the wild type but
Cbfa1 and Bone Development
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Figure 5. Disturbed Osteogenesis in Cbfa1
Mutant Mice
(a±c, e, and h) Endochondral and subperios-
teal ossification in the tibia of newborn wild-
type (a and e), heterozygous (b), and homozy-
gous (c and h) Cbfa1 mutant mice. The
growth-plate architecture is slightly less or-
ganized in heterozygous mice (b). Ossifica-
tion centers, subperiosteal ossification, and
formation of a marrow cavity are absent in
homozygous mice (c). Higher magnification
shows a periosteal osteoblast layer (arrow-
heads)and an active periosteal mesenchymal
cell layer in wild-type mice (e). In Cbfa12/2
mice (h), the mesenchymal cell layer is small
and inactive (arrowhead), and no osteoblasts
are present (arrowhead). Some mineralization
occurs within the cartilage (arrow).
(d andg). Clavicular development. Sections in
the plane of the clavicle show endochondral
ossification and cancellous bone containing
hematopoietically active marrow in 19.5 dpc
wild-type mice (d). In heterozygous mice, the medial end of the clavicle is cartilaginous but without any osteoblastic activity, while the remaining
medial and lateral parts consist of cellular mesenchyme (g).
(f and i) Alkaline-phosphatase staining. Alkaline-phosphatase activity was easily detectable in 17.5 dpc wild-type long bones (f), with intense
reactivity in the surface osteoblasts around the developing epiphyses (arrow), but was weak or absent in homozygotes (i).
1995). Therefore, the syntenic region on mouse chromo- ossification presumably also explains the mortality of
Cbfa12/2 mice from apparent respiratory distressshortlysome 17 was tested for linkage to the Ccd mutation,
which was originally induced on an inbred 102 strain after birth, presumably owing to inadequate support for
respiratory effort from a soft, cartilaginous rib cage. Al-using a variety of MIT microsatellite markers and DNA
from cast/cast, cast/C57BL10, cast/Ccd, and 102/102 though both intramembranous and endochondral ossifi-
cation are affected by Cbfa1 deficiency, the formerintercrosses. Linkage was readily established. We iden-
tified an approximately 2.5 cM deletion by demon- seems to be especially susceptible, since mice hetero-
zygous for the Cbfa1 mutation showed specific defectsstrating loss of the Ccd allele in affected animals. This
deletion included MIT markers D17Mit51, D17Mit137,
D17Mit52, D17Mit136, D17Mit176, D17Mit124, and
D17Mit105 (Figure 6b). Southern blot analysis of RFLPs
demonstrated that Mut was deleted, in addition to
Cbfa1, but excluded Tcte1, Tpx1, Nfya, D17Tu37, and
D17Tu40 from the deletion (Figure 6b). The deletion was
flanked on both sides by small (,5 cM) stretches where
the original 102 alleles had been maintained.
Discussion
We have demonstrated that the Cbfa1 gene is essential
for the differentiation of osteoblasts and thus for bone
formation during the development of the skeleton. Two
types of bone development have been distinguished
(Erlebacher et al., 1995). During mammalian embryogen-
esis, most bones are laid down initially as a framework
or anlage of hyaline cartilage in a process known as
Figure 6. Cbfa1 Deletion in Ccd Mutant Miceendochondral ossification. Subsequent ossification and
(a) RFLP analysis of the Cbfa1 gene in Ccd mutant mice. DNA frombone deposition occurs within this framework. Intra-
the offspring produced by intercrosses between M. castaneus andmembranous ossification generates principally the flat
C57BL/10 mice heterozygous for Ccd, and from the parental strains,
bones of the skull but also other bones, such as part of was analyzed. Southern blots containing DNA from cast/cast (A),
the clavicles, and is involved in adding new bone to cast/C57BL/10 (B), cast/Ccd (C), and C57BL/10 (D) mice digested
with ApaI orTaqI are shown.An EcoRI±HindIII fragment of the mousethe outer surfaces of long bones. It involves the direct
Cbfa1 cDNA representing the 39 portion of the translated sequencedevelopment of osteoblasts from mesenchymal tissue
was used as probe. The castaneus allele is indicated by open arrow-without an intervening cartilage model. In Cbfa12/2 mice,
heads, the C57BL/10 allele by closed arrowheads. Note the absenceboth intramembranous and endochondral ossification
of the C57BL/10 Cbfa1 allele in the Ccd mice.
are affected, since ossification of the entire skeleton is (b) Genomic organization of the Ccd locus as determined by allelic
absent. This defect presumably gives rise to the ob- differences between strains. The deleted markers and genes are
printed in italics.served small stature of Cbfa12/2 mice. The failure of
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in formation of the clavicle and closure of the cranial (Hamvas et al., 1996). We have mapped the extent of
the deletion in the Ccd mouse and shown that the Cbfa1fontanelles.
Chondrocytes, osteoblasts, and osteoclasts are the gene is within the segment of DNA that is deleted. Taken
together, these data establish a strong case that CBFA1major cell types that contribute to the skeleton (Erle-
bacher et al., 1995). Detailed histological analysis of is the gene that is mutated in human CCD.
In conclusion, we show that the Cbfa1 gene plays anCbfa12/2 mice showed a specific failure of osteoblastic
differentiation and failure to vascularize the marrow. essential role in osteoblast differentiation of the cellular
periosteal mesenchyme and consequent bone develop-Thus, osteoblasts were absent from all bones examined,
although chondrocytes were present. Moreover, there ment. This work, together with the analysis of Cbfa2-
and Cbfb-null mice, which shows that these genes arewas almost complete absence of alkaline phosphatase,
an early marker of osteoblast differentiation, in bone essential for the development of hematopoietic stem
cells or multipotential progenitors, clearly establishestissue from Cbfa12/2 mice. There were also no discern-
ible hematopoietic precursors associated with the bone the CBF family of transcription factors as playing impor-
tant but distinct roles in development. Moreover, thisstructures in these mice, demonstrating that ossification
is essential for the proper vascularization and coloniza- study provides a compelling example of the identifica-
tion of a candidate gene involved in a human genetiction of bone by marrow or that Cbfa1 is expressed in a
common ancestor between stromal cells and osteo- disease by the generation and analysis of a mouse mu-
tant by targeted mutagenesis.blasts. The endothelial precursors for marrow formation
also arise from the primitive periosteal mesenchymal
layer, indicating that the Cbfa1gene is essential to diver- Experimental Procedures
gent mesenchymal differentiation in this tissue. This
Construct Designwould be consistent with the failure of clavicular devel-
A murine 129/Sv genomic DNA library in l2001 (provided by T.opment, which is a unique process that is dependent
Rabbitts, LMB, Cambridge) was screened using a probe corre-on the coordinate activities of endochondral, as well as
sponding to nt 1±90 of the exon containing the Q/A repeat domain
membranous, bone formation (Huang et al., submitted) of the Cbfa1 gene. One genomic clone that contained a 17 kb insert
in heterozygous animals. was characterized further and used to construct thetargeting vector.
The role of Cbfa1 early in bone development is under- A 7 kb BglII±SacI fragment was subcloned into pSP72.This fragment
spans an exon containing the whole Q/A repeat domain of the Cbfa1scored by the analysis of Cbfa1 reporter expression.
gene. A positive selectable cassette was introduced at the NotI siteLacZ staining was first observed at 9.5 dpc, and by 10.5
to create the vector pCBFKN1. The cassette contains stop codonsdpc, staining was observed in the mesenchyme from
in all three frames, an independent ribosomal entry sequence (IRES)
which the shoulder bones develop. By 12.5 dpc, LacZ followed by the lacZ gene with an SV40 polyadenylation signal, and
activity was prominent throughout the developing skele- a neomycin phosphotransferase gene (MC1Neo poly(A); gift of Dr.
ton. Since osteoblasts are first identifiable at about 14.5 A. Smith, Centre for Genome Research, Edinburgh). A diphtheria
toxin A (DTA) expression cassette was inserted into pCBFKN1 out-dpc (Kaufman, 1992), these datademonstrate that Cbfa1
side the long arm of homology to create the targeting vectoris expressed in sites of the developing skeleton at a
pCBFKN2.stage preceding osteoblast differentiation by several
days. Furthermore, bone tissue represented clearly by
Transfection of ES Cells and Screeningfar the major site of expression of lacZ. Thus, the pattern
for Homologous Recombination
of expression of Cbfa1 fully explains the observed phe- GK129 and R1.3 ES cells (107/0.8 ml) were electroporated with 25
notype of Cbfa12/2 mice. Cbfa1 expression is detectable mg of SalI-digested targeting vector pCBFKN1 or pCBFKN2 DNA.
in all bones examined, and lack of Cbfa1 expression Electroporated cells were allowed to recover for 15 min at room
temperature and then plated onto mitomycin C-treated STO feederresults in a failure of both major mechanisms of ossifica-
layers at a density of 2 3 106/10 cm dish. ES cells were grown intion. The only nonskeletal defect observed, an increase
DMEM supplemented with nonessential amino acids, L-glutamine,in primitive nucleated erythrocytes, is likely to be a sec-
penicillin-streptomycin, 2-mercaptoethanol, 1000 U/ml leukemia in-ondary effect of the lack of hemotopoietic marrow devel-
hibitory factor (LIF) (ESGRO), and 17% FCS (all GIBCO±BRL). Me-
opment. dium was replaced 24 hr after electroporation with selection medium
The heterozygous Cbfa11/2 phenotype has a counter- containing 400 mg/ml G418 (GIBCO±BRL). Cells were maintained on
selection medium for 8 days, with selection medium replaced everypart in the human genetic disease called cleidocranial
day. G418-resistant colonies were picked, trypsinized, and seededdysplasia (CCD). CCD is an autosomal dominant disor-
onto mitotically inactivated STO feeder layers in 96-well plates. Afterder. The main symptoms of heterozygous patients are
a further 3±4 days, cells were split onto two 96-well plates, one fora patent anterior fontanelle, hypoplasia or aplasia of
subsequent freezing and storage, the other for DNA preparation.
the clavicle, a wide pubic symphysis, and short stature. DNA was analyzed after SacI digestion by Southern blot analysis
Although Cbfa11/2 mice are not obviously smaller than using probe A (Figure 1).
their wild-type littermates, they mirror precisely the
other symptoms. Human CCD maps to the short arm of Generation of Cbfa1 Mutant Mice
chromosome 6 (Mundlos et al., 1995; Ramesar et al., Correctly targeted cells were injected into C57BL/6 blastocysts.
Injected blastocysts were cultured overnight and then implanted1996). Human CBFA1 also maps to chromosome 6p21
into 2.5-days-pseudopregnant females. Chimeric mice were bred(Levanon et al., 1994). Interestingly, there is another
to C57BL/6 mice to yield mice heterozygous for the mutant allele.mouse model that also shows close similarities to hu-
Heterozygous mice were interbred and time mated to yield homozy-
man CCD (Sillence et al., 1987). This mouse mutant was gous mutant animals. All animals were kept under specific patho-
induced by gamma irradiation (Selby and Selby, 1978), gen-free conditions and in accordance with Home Office regula-
and the mutation has been shown to map to chromo- tions. The morning of the day on which the plug was found was
defined as 0.5 dpc. Mice were genotyped from tail DNA.some 17 in the same region as the mouse Cbfa1 gene
Cbfa1 and Bone Development
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Skeleton Preparations Geoffroy, V., Ducy, P., and Karsenty, G. (1995). A PEBP2 alpha/AML-1
related factor increases osteocalcin promoter activity through itsEmbryos were eviscerated and the skin was removed. After over-
night fixation in 95% ethanol, embryos were stained in Alcian blue binding to an osteoblast-specific cis-acting element. J. Biol. Chem.
270, 30973±30979.solution (150 mg Alcian blue, 800 ml 98% ethanol, 200 ml acetic
acid) overnight. After several hours in 95% ethanol, they were trans- Hamvas, R., Trachtulec, Z., Forejt, J., Williams, R.W., Arzt, K., Fi-
ferred to 2% KOH for 24 hr. After overnight staining in Alizarin red scher-Lindahl, K., and Silver, L.M. (1996). Encyclopedia of the mouse
solution (50 mg/l Alizarin red in 2% KOH), skeletons were cleared genome V. Mouse chromosome 17. Mammalian Genome 6, S281±
in 1% KOH/20% glycerol and stored in 50% ethanol/50% glycerol. S299.
Ito, Y. (1996). Structural alterations in the transcription factors
Histology PEBP2/CBF linked to four different types of leukemia. J. Cancer
Mice were dissected with a binocular microscope, fixed in 10% Res. Clin. Oncol. 122, 266±274.
formalin, processed, and embedded in paraffin. Serial sections were
Kaufman, M.H., ed. (1992). The Atlas of Mouse Development (Santaken at 4 mm and stained with hematoxylin and eosin.
Diego, California: Academic Press), pp. 495±506.Cryostat sections at 6 mm of snap-froxen long bones from 17.5
Levanon, D., Negreanu, V., Bernstein, Y., Bar-Am, I., Avivi, L., anddpc embryos were stained by the alkaline phosphatase method
Groner, Y. (1994). AML1, AML2 and AML3, the human membersusing Fast red TR as an end-product (Malik and Damon, 1982).
of the runt domain gene-family: cDNA structure, expression, andDevelopment was optimal at 5 min, followed by hematoxylin coun-
chromosomal localization. Genomics 23, 425±432.terstain.
Malik, D.Y., and Damon, M.E. (1982). Development of alkaline phos-
phatase to give a less soluble red end-product. J. Clin. Pathol. 35,Staining for LacZ Activity
1092±1094.Cbfa11/2 and Cbfa12/2 embryos were stained intact as whole
mounts as previously described (Beddington et al., 1989). No stain- Mundlos, S., Mulliken, J.B., Abramson, D.L., Warman, M.L., Knoll,
ing was observed in control Cbfa11/1 embryos. J.H., and Olsen, B.R. (1995). Genetic mapping of cleidocranial dys-
plasia and evidence of a microdeletion in one family. Hum. Mol.
Genet. 4, 71±75.Mapping of the Mouse Ccd Locus
The Ccd mutation was induced by gamma irradiation on an inbred Okuda, T., van Deursen, J., Hiebert, S.W., Grosveld, G., and Down-
102 strain and subsequently crossed-over many (.10) generations ing, J.R. (1996). AML1, thetarget of multiplechromosomal transloca-
onto a C57BL/10 background. For mapping of the Ccd locus, Ccd/1 tions in human leukemia, is essential for normal fetal liver hemato-
mice were crossed with C3H, DBA/2J, and M. castaneus inbred poiesis. Cell 84, 321±330.
strains. Affected offspring (F1) were crossed with the parental wild- Ramesar, R.S., Greenberg, J., Martin, R., Goliath, R., Bardien, S.,
type strain. The phenotype of F2 offspring was determined through Mundlos, S., and Beighton, P. (1996). Mapping of the gene for cleido-
skeletal preparations, and tail DNA was extracted for mapping pur- cranial dysplasia in the historical Cape Town (Arnold) kindred and
poses. Mapping was performed with MIT microsatellite markers evidence for locus homogeneity. J. Med. Genet. 33, 511±514.
from mouse chromosome 17. Several genes and anonymous DNA
Sasaki, K., Yagi, H., Bronson, R.T., Tominaga, K., Matsunashi, T.,markers from this region were tested by Southern blot RFLPs using
Deguchi, K., Tani, Y., Kishimoto, T., and Komori, T. (1996). Absencecast/cast, cast/C57BL10, cast/Ccd, and 102/102 DNA.
of fetal liver hematopoiesis in mice deficient in transcriptionalcoacti-
vator core binding factor b. Proc. Natl. Acad. Sci. USA 93, 12359±Acknowledgments
12363.
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